But you're generally limited to getting what may or may not be a useful code, which you then usually need to take to a forum to figure out ... Suppliers of review products do not have any input into ...

With new draft guidance, FDA continues prior efforts to reduce the need for comparative clinical studies in biosimilar development and speed ...